In 2022, a slightly higher number of people in the Netherlands contracted diseases covered by the National Immunisation Programme (NIP) compared to 2021. This increase is likely due to the easing of coronavirus measures, such as social distancing.
European prize for mobile vaccination units
The Netherlands’ mobile vaccination units (prikbussen) have been selected as a best-practice method for the European project ‘Overcoming Obstacles to Vaccination’.
Smokers inhale more tar, nicotine and carbon monoxide when measured with WHO method
RIVM has measured the amount of tar, nicotine and carbon monoxide (TNCO) in all filter cigarettes sold in the Netherlands with the WHO Intense method.
RIVM publishes new data from manufacturers on tobacco products
On behalf of the Dutch Ministry of VWS (Health, Welfare and Sport), RIVM has published new data on tobacco products. For the first time, these data include the ingredients of e-cigarettes, heated tobacco products and herbal smoking products.
Darker cigarettes and other measures to make cigarettes less appealing
There are a number of measures that can be implemented to make cigarettes less appealing and less addictive. For example, manufacturers could make cigarettes a darker colour. They could also stop using ingredients like sugars and flavourings.
RIVM prepares a recommended list of banned substances in tobacco products and e-cigarettes
The goal of the European Tobacco Products Directive is to make tobacco products and e-cigarettes less harmful, addictive and attractive. The directive does not specifically state which substances are not allowed in tobacco products and e-cigarettes.
Provisional figures on participation in the National Immunisation Programme
According to RIVM’s registration system, at least 90% of babies have been vaccinated against mumps, measles and rubella (MMR).
Side effect reports National Immunisation Programme 2021
Last year, the Netherlands Pharmacovigilance Centre Lareb received 1,462 reports of possible side effects from vaccines administered under the National Immunisation Programme. As was the case in previous years, no new, disconcerting side effects have
Participation in National Immunisation Programme shows slight decrease
Participation in the National Immunisation Programme has fallen slightly, showing a decrease of 1 to 2 percentage points.